$A2.9 million for research study

15 March 2023

The Sugammadex, neostigmine and postoperative pulmonary complications (SNaPP) study has been awarded funding from the Australian Medical Research Future Fund

A 3500-patient randomised controlled trial into the reversal of muscle relaxant drugs after general anaesthesia has received $2.9 million from the Australian Government’s Medical Research Future Fund.

The study’s Principal Investigator, ANZCA fellow Professor Kate Leslie AO, said: “A hidden pandemic of complications after surgery is occurring in Australia and around the world. These complications lead to prolonged illness and decreased quality of life for patients and increased costs for the healthcare system. The goal of our study is to reduce the burden of these complications.”

“With the SNaPP Study we will once again join forces with investigators and trial coordinators in Australia, New Zealand and Hong Kong to answer one of the most hotly debated questions in our specialty.”

Our media release has more information.  

Last updated 15:23 15.03.2023